CBS 60 MINUTES HAS CLEAR UNDERSTANDING OFMESH,
While the West Virginia Mesh MDL’s Plaintiff’s Steering Committee
Continues to Ignore the Truth.
“LIGHT WEIGHT LARGE PORE v. HEAVYWEIGHT SMALL PORE”
This is the strawman used in multiple bellwether trials in Mesh Multidistrict Litigation in West Virginia. It completely ignores the array of physical and chemical properties of Polypropylene Synthetic Surgical Mesh which make it incompatible with the human body.
Not to mention, the inherent manufacturing defects which I personally identified
as a manufacturing and device expert. Mesh is defective whether implanted or on the shelf.
However, leadership on the Plaintiffs Steering Committee, and you know who you are, have ignored a world of technical information readily available to you, through your discovery and your experts, that makes ALL polypropylene synthetic surgical mesh defective.
No, you are off to new MDL’s for Ethicon Physiomesh and Atrium C-Qur. You have abandoned over 13,000 women, PTO 273, whose cases have been dismissed without prejudice by Judge Joseph Goodwin because…. now here’s another strawman…. these thousands of women have not had surgery to remove the permanently implanted mesh that is like removing gum from your hair, a strawman created by the Plaintiff’s Steering Committee to protect the companies.
While I know many plaintiff’s attorneys have no control over their own mesh cases, and I am not talking to you, the Plaintiffs Steering Committee has spent, and received, hundreds of millions of dollars and polypropylene synthetic surgical mesh IS STILL ON THE MARKET.
The 3 men listed below from the 60 Minutes segment presented enough facts that Polypropylene Synthetic Surgical Mesh should have been recalled from the market years ago and NEVER implanted in humans, men or women and you can’t prove it in court.
Link to CBS 60 Minutes Segment 05-13-2018:
BOSTON SCIENTIFIC COURT DOCUMENTS
“In 2005, Chevron Phillips cut off Boston Scientific's supply of Marlex. Later, when Boston Scientific appealed, Chevron Phillips replied, "We are simply not interested in this business at any price." Boston Scientific estimated that it would run out of Marlex by 2012. George Vialle, director of Global Supply Chain wrote, this plastic resin "supports a $120 million in annual revenue… I can not [sic] overstate the importance of getting more." Boston Scientific had to have Chevron Phillips Marlex because that plastic was already accepted by the FDA.
1. DR. MICHAEL MARGOLIS
“Dr. Michael Margolis is a surgeon who has removed 350 mesh implants. He's been a witness in lawsuits against Boston Scientific.
“Dr. Michael Margolis: The slings I've removed are substantially altered in their architecture. They are shrunk by at least 50% in width; they are encased in scar tissue. The pores here, these openings here are shrunk substantially.”
2. DUANE PRIDDY
“Duane Priddy has been a witness in mesh lawsuits, but he is not part of any litigation against Boston Scientific. He explained to us that oxygen breaks up polypropylene. The plastic has antioxidant additives but they dissipate over time.”
3. CHRIS DeARMITT
“Chris DeArmitt is a plastics engineer who researched Boston Scientific for one of the women suing the company.”
“Chris DeArmitt: They looked everywhere. They looked at least 20 different companies all around the world. They were looking for stocks of material.”